Riskpilot← Back to searchSign inGet full accessMENTIS CURA AS
ASActiveOrg 916997477Gaustadalléen 21, 0349 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employeeswww.mentiscura.com
Revenue 2022
NOK 6M
-3% vs 2021
EBITDA margin
-61.5%
-182% vs 2021
Equity ratio
-185.2%
Financial strength
Net profit 2022
NOK -3,7M
+81% vs 2021
| Revenue | NOK 6M | -3% |
| EBITDA | NOK -3,7M | -182% |
| Net profit | NOK -3,7M | +81% |
| Total assets | NOK 2,3M | -18% |
| Equity | NOK -4,2M | -772% |
| Employees | 0 | — |
Legal name
MENTIS CURA AS
Org number
916997477
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. april 2016
Share capital
NOK 6 605 251
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder alene. Styrets leder alene.
Company purpose
Utvikling og kommersialisering av diagnostiske metoder og teknikker innenfor medisin og fysiologi.
Address
Gaustadalléen 21, 0349 Oslo
Email
asta.mekkin.palsdottir@mentiscura.com
Website
www.mentiscura.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | 689 | 3 375 | 5 189 | 2 502 | 3 011 | 6 194 | 6 011 |
| Staff expenses | −385 | −3 558 | −7 697 | −0 | −0 | −0 | −0 |
| EBITDA | −1 859 | −16 860 | −24 447 | 125 796 | −13 797 | 4 502 | −3 695 |
| Depreciation & amort. | −0 | −4 | −7 | −150 007 | −17 | −11 935 | −0 |
| EBIT | −1 859 | −16 864 | −24 454 | −24 211 | −13 814 | −7 434 | −3 695 |
| Net financials | −1 | 13 | 763 | −150 229 | 1 153 | −12 060 | −0 |
| Profit before tax | −1 859 | −16 851 | −23 691 | −174 440 | −12 661 | −19 494 | −3 695 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 859 | −16 851 | −23 691 | −174 440 | −12 661 | −19 494 | −3 695 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Total assets | 140 852 | 165 542 | 155 314 | 20 672 | 17 280 | 2 756 | 2 254 |
| Equity | 138 611 | 153 279 | 141 813 | 10 861 | −1 800 | −479 | −4 174 |
| Long-term debt | 0 | 0 | 0 | 0 | 12 430 | 205 | 1 505 |
| Short-term debt | 2 242 | 12 263 | 13 501 | 9 811 | 6 651 | 3 030 | 4 923 |
| Total debt | 2 242 | 12 263 | 13 501 | 9 811 | 19 081 | 3 235 | 6 428 |
EBITDA margin
-61.5%
This company
15.8%
Market median
-489% vs market
20162022
Equity ratio
-185.2%
This company
38.2%
Market median
-585% vs market
20162022
Return on equity
-369549700.0%
This company
18.4%
Market median
-2008422383% vs market
20162022
Net profit margin
-61.5%
This company
8.1%
Market median
-859% vs market
20162022
Asset turnover
2.67×
This company
1.12×
Market median
+138% vs market
20162022
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20162022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CL Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
North Murray As | Company | 21.1% | 21.1% | 2024 |
Stratel As | Company | 12.4% | 12.4% | 2024 |
Nýsköpunarsjóður Atvinnulífsins | Company | 10.8% | 10.8% | 2024 |
| Individual | 10.8% | 10.8% | 2022 | |
Rondane Holding As | Company | 10.5% | 10.5% | 2024 |
Abelsnes Invest As | Company | 6.5% | 6.5% | 2024 |
| Individual | 5.6% | 5.6% | 2022 | |
Arcus Ehf. | Company | 5.6% | 5.6% | 2024 |
Bitteborgen As | Company | 5.5% | 5.5% | 2024 |
Frax As | Company | 2.6% | 2.6% | 2024 |
New Business Venture Fund | Company | 2.5% | 2.5% | 2024 |
Arion Banki Hf. | Company | 2.2% | 2.2% | 2024 |
| Individual | 2.2% | 2.2% | 2022 | |
Kristinn Johnsen | Company | 1.7% | 1.7% | 2024 |
Skarv Invest As | Company | 1.5% | 1.5% | 2024 |
Arat As | Company | 1.2% | 1.2% | 2024 |
Fm Fjárfesting Ehf. | Company | 1.2% | 1.2% | 2024 |
| Individual | 1.2% | 1.2% | 2022 | |
Styre & Stell As | Company | 1.2% | 1.2% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MENTIS CURA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claire Louise Button | Chief Executive Officer | 0 companies |
| Jan Fikkan | Board of Directors | 0 companies |
| Fridrik Fridriksson | Chairman | 0 companies |
| Trond Håkon Lutdal | Board of Directors | 0 companies |
| Joanne Mary Hackett | Board of Directors | 0 companies |
| Joachim Dericq Paasche | Board of Directors | 0 companies |
| Audun Abelsnes | Board of Directors | 0 companies |